Form 4 holding
President & COO
LIGAND PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 50,777
- Estimated value
- $5,182,001
- Report date
- 23 Sep 2024
- Price
- $102.05
- Ownership
- Direct
Matthew E. Korenberg - President & COO at LIGAND PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- President & COO
- Issuer ticker
- LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew E. Korenberg since 28 Sep 2025
Reported holdings for Matthew E. Korenberg in LIGAND PHARMACEUTICALS INC
Form 4 holding
President & COO
LIGAND PHARMACEUTICALS INC
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 58,544
- Estimated value
- Report date
- 27 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President & COO
LIGAND PHARMACEUTICALS INC
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 42,436
- Estimated value
- Report date
- 23 Sep 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew E. Korenberg in LIGAND PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.